PubMed:32472611
Annnotations
maxiaofeng52_800_3
{"project":"maxiaofeng52_800_3","denotations":[{"id":"T1","span":{"begin":184,"end":213},"obj":"DP"},{"id":"T2","span":{"begin":48,"end":59},"obj":"CI"},{"id":"T3","span":{"begin":169,"end":180},"obj":"CI"}],"text":"Novel dose escalation to predict treatment with hydroxyurea (NDEPTH): A randomized controlled trial of a dose-prediction equation to determine maximum tolerated dose of hydroxyurea in pediatric sickle cell disease.\n"}
wangzhuo19_800_3
{"project":"wangzhuo19_800_3","denotations":[{"id":"T1","span":{"begin":48,"end":59},"obj":"CI"},{"id":"T2","span":{"begin":169,"end":180},"obj":"CI"},{"id":"T4","span":{"begin":184,"end":213},"obj":"DP"}],"text":"Novel dose escalation to predict treatment with hydroxyurea (NDEPTH): A randomized controlled trial of a dose-prediction equation to determine maximum tolerated dose of hydroxyurea in pediatric sickle cell disease.\n"}